{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:35Z","timestamp":1786991315572,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaip.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T21:05:35Z","timestamp":1504731935000},"page":"528-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma"],"prefix":"10.1016","volume":"6","author":[{"given":"Grazyna","family":"Bochenek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Stachura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Szafraniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Plutecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Nizankowska-Mogilnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Sladek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","article-title":"Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease","volume":"94","author":"Mascia","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1034\/j.1398-9995.2002.13508.x","article-title":"Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity","volume":"57","author":"Kowalski","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1398-9995.1997.tb00966.x","article-title":"Measurement of leukotrienes in the urine: strategies and applications","volume":"52","author":"Kumlin","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","article-title":"Urinary leukotriene E4 in bronchial asthma","volume":"5","author":"Smith","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","article-title":"Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics","volume":"146","author":"Kumlin","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A\u00a0controlled study of 9\u03b1,11\u03b2-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hypeplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.rmed.2006.03.017","article-title":"Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics","volume":"100","author":"Micheletto","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cea.12797","article-title":"Metabolomic analysis identifies diagnostic biomarkers for aspirin-exacerbated respiratory disease","volume":"47","author":"Ban","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","article-title":"Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin","volume":"71","author":"Pleskow","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Ni\u017cankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)\u2014classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib17","author":"Global Strategy for Asthma Management and Prevention"},{"key":"10.1016\/j.jaip.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaip.2016.11.004","article-title":"Urinary leukotriene E4 to determine aspirin intolerance in asthma: a systematic review and meta-analysis","volume":"5","author":"Hagan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.20452\/pamw.1379","article-title":"Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4","volume":"122","author":"Celejewska-W\u00f3jcik","year":"2012","journal-title":"Pol Arch Int Med"},{"key":"10.1016\/j.jaip.2017.07.001_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of severe asthma","volume":"22","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.rmed.2012.10.020","article-title":"Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey","volume":"107","author":"Moon","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.001_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaip.2016.03.004","article-title":"Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity","volume":"4","author":"Divekar","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.07.001_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1398-9995.2009.02206.x","article-title":"Elevated urinary leukotriene E4 excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA","volume":"60","author":"Sanak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.001_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4168\/aair.2011.3.4.256","article-title":"Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma","volume":"3","author":"Chang","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2017.07.001_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.aller.2011.05.015","article-title":"Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey","volume":"40","author":"Bavbek","year":"2012","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2017.07.001_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.07.001_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cea.12359","article-title":"Aspirin-intolerant asthma in the population: prevalence and important determinants","volume":"45","author":"Eriksson","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.07.001_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","article-title":"Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease","volume":"109","author":"Bochenek","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.001_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000141652","article-title":"High-resolution computed tomography evaluation of peripheral airways in asthma patients: comparison of focal and diffuse trapping","volume":"77","author":"Miko\u015b","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.jaip.2017.07.001_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic rhinosinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:57Z","timestamp":1761974157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817305226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213219817305226"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.07.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}